Publications by authors named "Jeremy D Shapiro"

Claim this Profile
T
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.
Michael Michael, Rachel Wong, Sanjeev Gill, Andrew H Strickland, Nick Pavlakis, Jeremy D Shapiro

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial.
Jeanne Tie, Yuxuan Wang, Serigne N Lo, Kamel Lahouel, Joshua D Cohen, Jeremy D Shapiro

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical Outcome.
Grace Y Kim, Azim Jalali, Grace Gard, Justin M Yeung, Hieu Chau, Jeremy D Shapiro

Clin Colorectal Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17.
Arjun Gupta, Christopher J O'Callaghan, Liting Zhu, Derek J Jonker, Ralph P W Wong, Jeremy D Shapiro

J Natl Cancer Inst· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
Di Maria Jiang, Shruti Parshad, Luna Zhan, Hao-Wen Sim, Lillian L Siu, Jeremy D Shapiro

Clin Colorectal Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and metabolomic characterization of Brivanib-Induced hypertension in metastatic colorectal cancer.
Jodi I Rattner, Karen A Kopciuk, Hans J Vogel, Patricia A Tang, Jeremy D Shapiro

Cancer Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial.
Arjun Gupta, Christopher J O'Callaghan, Liting Zhu, Derek J Jonker, Ralph P W Wong, Jeremy D Shapiro

JCO Oncol Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early detection of treatment futility in patients with metastatic colorectal cancer.
Jodi I Rattner, Karen A Kopciuk, Hans J Vogel, Patricia A Tang, Jeremy D Shapiro

Oncotarget· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial.
Elisa Fontana, Gift Nyamundanda, David Cunningham, Dongsheng Tu, Maggie C U Cheang, Jeremy D Shapiro

JCO Precis Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.
Wassim Abida, David Campbell, Akash Patnaik, Jeremy D Shapiro, Brieuc Sautois

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019.
David K Lau, Matthew Burge, Amitesh Roy, Ian Chau, Daniel G Haller, Jeremy D Shapiro

Expert Rev Anticancer Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer.
Christine Koulis, Raymond Yap, Rebekah Engel, Thierry Jardé, Simon Wilkins, Jeremy D Shapiro

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20.
J Connor Wells, Dongsheng Tu, Lillian L Siu, Jeremy D Shapiro, Derek J Jonker

Clin Colorectal Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.
Jeremy D Shapiro, Subotheni Thavaneswaran, Craig R Underhill, Kristy P Robledo, Christos S Karapetis

Clin Colorectal Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality and impact of eviQ Cancer Treatments Online (www.eviq.org.au): the medical oncologist's perspective.
Lydia P Y Loke, Tina Y T Chen, Craig R Lewis, Robyn L Ward, Shelley A Rushton, Jeremy D Shapiro

Asia Pac J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.
Eva Segelov, Subotheni Thavaneswaran, Paul M Waring, Jayesh Desai, Kristy P Robledo, Jeremy D Shapiro

J Clin Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.
Timothy J Price, Subotheni Thavaneswaran, Matthew Burge, Eva Segelov, Daniel G Haller, Jeremy D Shapiro

Expert Rev Anticancer Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.
Geoffrey Liu, Dongsheng Tu, Marcia Lewis, Dangxiao Cheng, Leslie A Sullivan, Jeremy D Shapiro

Clin Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.
Timothy J Price, Eva Segelov, Matthew Burge, Daniel G Haller, Niall C Tebbutt, Jeremy D Shapiro

Expert Rev Anticancer Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.
Christos S Karapetis, Derek Jonker, Manijeh Daneshmand, Jennifer E Hanson, Christopher J O'Callaghan, Jeremy D Shapiro

Clin Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.
Jolie Ringash, Heather-Jane Au, Lillian L Siu, Jeremy D Shapiro, Derek J Jonker

Cancer· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial incentives in cancer care and impact on prescribing practice.
Hui-Li Wong, Kathryn M Field, Jeremy D Shapiro, Joseph J McKendrick, Peter Gibbs

J Clin Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial.
Lillian L Siu, Jeremy D Shapiro, Derek J Jonker, Chris S Karapetis, John R Zalcberg

J Clin Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current opinion on optimal treatment for colorectal cancer.
Timothy J Price, Eva Segelov, Matthew Burge, Daniel G Haller, Stephen P Ackland, Jeremy D Shapiro

Expert Rev Anticancer Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of advanced gastric cancer.
Timothy J Price, Jeremy D Shapiro, Eva Segelov, Christos S Karapetis, Nick Pavlakis

Expert Rev Gastroenterol Hepatol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis